Jobby John
Semaglutide and Tirzepatide are both injectable medications. Semaglutide, known as Ozempic® for diabetes and Wegovy® for weight loss, helps lower blood sugar and aid in weight loss. Tirzepatide, sold under the brand names Mounjaro® for diabetes and now Zepbound® for weight loss, is a newer medication that works similarly. Both have gained popularity, but that's made them harder to find.
Both Semaglutide and Tirzepatide are patented, meaning the companies that created them have exclusive rights to make and sell them for about 20 years. These rights can sometimes be extended under special circumstances.
During shortages, like what we're seeing with Semaglutide and Tirzepatide allow compounding pharmacies to make alternative versions. This is only allowed when the FDA confirms a shortage and approves these versions for safety and quality.
Sometimes, patients need a medication tailored to their specific needs, like an allergy to an ingredient or a different dosage. Compounding pharmacies can make these customized versions of both Semaglutide and Tirzepatide.
At Nimbus Healthcare, we ensure access to both Semaglutide and Tirzepatide, even during shortages. We provide safe, FDA-approved compounded versions.
Compounding pharmacies play a vital role in the United States healthcare system, and their services should be valued and supported.
If you need a special version of Semaglutide or Tirzepatide, Nimbus Healthcare is here to assist. We connect you with healthcare providers and compounding pharmacies to ensure you get the right medication. Contact us for your medication needs - support@nimbushealthcare.com or click here to get started with your WeightWiseRX™ journey.
